EvolveImmune Therapeutics
Jennifer Zeiger started their work experience as a Research Associate at EvolveImmune Therapeutics in January 2022. Prior to that, they worked at the University of Connecticut from 2019 to 2021. At the University of Connecticut, Jennifer held multiple roles, including Graduate Research Assistant from December 2019 to December 2021. Jennifer also served as a Graduate Teaching Assistant, assisting with biochemistry and microbiology laboratory preparation, and as a responsible teaching assistant for two laboratory sections of Principles of Biology.
Jennifer Zeiger received their Bachelor's degree in Genetics and Biotechnology from the University of New Haven. Jennifer pursued further education at the University of Connecticut, where they obtained a Master of Science degree in Cell/Cellular and Molecular Biology.
EvolveImmune Therapeutics
2 followers
EvolveImmune Therapeutics is a next-generation immunotherapy platform company based in Farmington and Branford, CT. Building upon research that originates from the Sidi Chen Lab at Yale University, EvolveImmune is leveraging a novel in vivo target discovery platform to develop a broad portfolio of first-in-class molecules for unmet needs in oncology and autoimmune diseases.